Tumor-reactive clonotype dynamics underlying clinical response to TIL therapy in melanoma
Chiffelle, J.; Barras, D.; Petremand, R.; Orcurto, A.; Bobisse, S.; Arnaud, M.; Auger, A.; Navarro Rodrigo, B.; Ghisoni, E.; Sauvage, C.; Saugy, D.; Michel, A.; Murgues, B.; Fahr, N.; Imbimbo, M.; Ochoa-de-Olza, M.; Latifyan, S.; Crespo, I.; Benedetti, F.; Genolet, R.; Queiroz, L.; Schmidt, J.; Homicsko, K.; Zimmermann, S.; Michielin, O.; Bassani-Sternberg, M.; Kandalaft, L. E.; Dafni, U.; Corria Osorio, J.; Trueb, L.; Dangaj Laniti, D.; Harari, A.; Coukos, G.
Show abstract
The profiles, specificity and dynamics of tumor-specific clonotypes that are associated with clinical response to adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TILs) remain unclear. Using single-cell RNA/TCR-sequencing, we tracked TIL clonotypes from baseline tumors to ACT products and post-ACT blood and tumor samples in melanoma patients treated with TIL-ACT. Patients with clinical responses had baseline tumors enriched in tumor-reactive TILs, which were more effectively mobilized upon in vitro expansion, yielding products with higher numbers of tumor-specific CD8+ cells, which also preferentially infiltrated tumors post-ACT. Conversely, lack of clinical responses was associated with tumors devoid of tumor-reactive resident clonotypes, and with cell products mostly composed of blood-borne clonotypes mainly persisting in blood but not in tumors post-ACT. Upon expansion, tumor-specific TILs lost the specific signatures of states originally exhibited in tumors, including exhaustion, and in responders acquired an intermediate exhausted effector state after tumor engraftment, revealing important functional cell reinvigoration.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Two-Stage CD8+ CAR T-Cell Differentiation in Patients with Large B-Cell Lymphoma 98%
- Projecting single-cell transcriptomics data onto a reference T cell atlas to interpret immune responses 98%
- LAG-3 blockade reactivates the CD8+ T cell expansion program to re-expand contracted clones in the tumor 98%
Similar papers in this journal
- Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumour immunity 96%
- A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma 96%
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 96%
Similar papers in this journal
Similar papers in this journal
- Microenvironmental correlates of immune checkpoint inhibitor response in human melanoma brain metastases revealed by T cell receptor and single-cell RNA sequencing 98%
- Holistic Characterization of Tumor Monocyte-to-Macrophage Differentiation Integrates Distinct Immune Phenotypes in Kidney Cancer 98%
- Clonal spreading of tumor-infiltrating T cells underlies the robust antitumor immune responses 97%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.